Susceptibility or resistance of praziquantel in human schistosomiasis: a review

W Wang, L Wang, YS Liang - Parasitology research, 2012 - Springer
Since praziquantel was developed in 1970s, it has replaced other antischistosomal drugs to
become the only drug of choice for treatment of human schistosomiases, due to high …

Macrophage activation governs schistosomiasis‐induced inflammation and fibrosis

L Barron, TA Wynn - European journal of immunology, 2011 - Wiley Online Library
Macrophages regulate the initiation, maintenance, and resolution of chronic inflammatory
responses and their function depends on their activation status. Studies in mice infected with …

Praziquantel ameliorates CCl4‐induced liver fibrosis in mice by inhibiting TGF‐β/Smad signalling via up‐regulating Smad7 in hepatic stellate cells

J Liu, D Kong, J Qiu, Y Xie, Z Lu, C Zhou… - British journal of …, 2019 - Wiley Online Library
Background and Purpose Praziquantel is a schistosomicide, which has been used for more
than 30 years due to its efficiency, safety, and mild side effects. Previous studies showed that …

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis

NM El-Lakkany, OA Hammam, WH El-Maadawy… - Parasites & vectors, 2012 - Springer
Background Praziquantel (PZQ) is an isoquinoline derivative (2-cyclohexylcarbonyl-1, 2, 3,
6, 7, 11b-hexahydro-4H-pyrazino {2, 1-a}-isoquinoline-4-one), and is currently the drug of …

The journey to discovering a flatworm target of praziquantel: a long TRP

SK Park, JS Marchant - Trends in parasitology, 2020 - cell.com
Infections caused by parasitic flatworms impose a considerable worldwide health burden.
One of the most impactful is schistosomiasis, a disease caused by parasitic blood flukes …

Drug repurposing for schistosomiasis: combinations of drugs or biomolecules

MJ Gouveia, PJ Brindley, F Gärtner, JMC Costa… - Pharmaceuticals, 2018 - mdpi.com
Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently
relies on a single drug, praziquantel, and despite its efficacy against the all schistosome …

Characteristics of IL‐17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver

D Chen, X Luo, H Xie, Z Gao, H Fang, J Huang - Immunology, 2013 - Wiley Online Library
S chistosomiasis japonica is a severe tropical disease caused by the parasitic worm S
chistosoma japonicum. Among the most serious pathological effects of S. japonicum …

Pattern recognition receptor signaling and innate immune responses to schistosome infection

N Dibo, X Liu, Y Chang, S Huang, X Wu - Frontiers in Cellular and …, 2022 - frontiersin.org
Schistosomiasis remains to be a significant public health problem in tropical and subtropical
regions. Despite remarkable progress that has been made in the control of the disease over …

Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice

RS Almeer, MF El-Khadragy, S Abdelhabib… - PloS one, 2018 - journals.plos.org
Schistosomiasis is a widespread parasitic infection that affects humans, as well as wild and
domestic animals. It ranks second after malaria, with a significant health and socio-economic …

The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon …

LJ Song, XR Yin, SS Mu, JH Li, H Gao… - Frontiers in …, 2020 - frontiersin.org
Liver fibrosis can result from various causes and could progress to cirrhosis and cancer;
however, there are no effective treatments due to that its molecular mechanism is unclear …